Clinical Variables Affecting Survival in Patients with Decompensated Diastolic Versus Systolic Heart Failure

Overview

Journal Clin Res Cardiol

Specialty Cardiology & Vascular Diseases

Date 2009 Feb 17

PMID 19219395

Citations 11

Authors

Oleg Gorelik

Dorit Almoznino-Sarafian

Miriam Shteinshnaider

Irena Alon

Irma Tzur

Ilya Sokolsky

Shai Efrati

Zoanna Babakin

David Modai

Natan Cohen

Affiliations

Soon will be listed here.

Abstract

Background: The impact of various clinical variables on long-term survival of patients with acutely decompensated diastolic heart failure (DHF) compared to systolic heart failure (SHF) has not been sufficiently investigated.

Methods: Clinical, laboratory, electrocardiographic and echocardiographic data were collected and analyzed for all-cause mortality in 473 furosemide-treated patients aged >or=60 years, hospitalized for acutely decompensated HF.

Results: Diastolic heart failure patients (n = 183) were more likely to be older, female, hypertensive, obese, with shorter preexisting HF duration, atrial fibrillation, lower New York Heart Association (NYHA) class, lower maintenance furosemide dosages, and to receive calcium antagonists. The SHF group (290 patients) demonstrated prevailing coronary artery disease, nitrate or digoxin treatment, and electrocardiographic conduction disturbances (P <or= 0.01 in all comparisons). On median 35-month follow-up, the respective one-, three- and five-year survival rates were 82%, 48% and 33% in DHF versus 74%, 46% and 30% in SHF (P = 0.3). Higher furosemide daily dosage at discharge (OR = 1.24, 95% CI = 1.11-1.37, P < 0.001), increasing age (OR = 1.29, 95% CI = 1.09-1.54, P = 0.003), peripheral arterial disease (OR = 1.47, 95% CI = 1.02-2.13, P = 0.043), and a history of stroke (OR = 1.44, 95% CI = 0.98-2.1, P = 0.066) were most significantly associated with shorter survival in SHF. DHF, in turn, demonstrated higher NYHA class (OR = 2.52, 95% CI = 1.48-4.29, P < 0.001), history of non-advanced malignancy (OR = 2.51, 95% CI = 1.3-4.85, P = 0.012), and atrial fibrillation (OR = 1.6, 95% CI = 0.97-2.64, P = 0.066). Antilipid treatment (OR = 0.56, 95% CI = 0.3-1.02, P = 0.049) predicted better survival.

Conclusion: In-patients with acutely decompensated DHF differ from similar SHF subjects with respect to prognostic significance of a number of clinical variables. This observation might carry practical implications.

Citing Articles

Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population-the CARLA study.

Tiller D, Russ M, Greiser K, Nuding S, Ebelt H, Kluttig A PLoS One. 2013; 8(3):e59225.

PMID: 23555000 PMC: 3598658. DOI: 10.1371/journal.pone.0059225.

Prognostic Factors for Survival at 6-Month Follow-up of Hospitalized Patients with Decompensated Congestive Heart Failure.

Cheraghi M, Sadeghi M, Sarrafzadegan N, Pourmoghadas A, Ramezani M ARYA Atheroscler. 2012; 6(3):112-7.

PMID: 22577426 PMC: 3347826.

Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure.

Arnaudis B, Lairez O, Escamilla R, Fouilloux A, Fournier P, Monteil B Clin Res Cardiol. 2012; 101(9):717-26.

PMID: 22484345 DOI: 10.1007/s00392-012-0450-4.

Early remodeling processes as predictors of diastolic function 5 years after reperfused acute myocardial infarction and intracoronary progenitor cell application.

Fischer-Rasokat U, Honold J, Seeger F, Fichtlscherer S, Schachinger V, Dimmeler S Clin Res Cardiol. 2011; 101(3):209-16.

PMID: 22105229 DOI: 10.1007/s00392-011-0382-4.

Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study.

Schoenenberger A, Schoenenberger-Berzins R, Auf der Maur C, Suter P, Vergopoulos A, Erne P Clin Res Cardiol. 2011; 101(3):159-64.

PMID: 22057652 DOI: 10.1007/s00392-011-0376-2.

References

Dungen H, Apostolovic S, Inkrot S, Tahirovic E, Krackhardt F, Pavlovic M . Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial. Clin Res Cardiol. 2008; 97(9):578-86. DOI: 10.1007/s00392-008-0681-6. View

Chatterjee K, Massie B . Systolic and diastolic heart failure: differences and similarities. J Card Fail. 2007; 13(7):569-76. DOI: 10.1016/j.cardfail.2007.04.006. View

Dubourg O, Gueret P, Beauchet A, Nisse-Durgeat S, Ducardonnet A . Focale: study of systolic and diastolic heart failure in a French elderly population. Int J Cardiol. 2007; 124(2):188-92. DOI: 10.1016/j.ijcard.2007.01.050. View

Lewis B, Shotan A, Gottlieb S, Behar S, Halon D, Boyko V . Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: the Israel Nationwide Heart Failure Survey. Isr Med Assoc J. 2007; 9(4):234-8. View

Gottlieb S, Baruch L, Kukin M, Bernstein J, Fisher M, Packer M . Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol. 1990; 16(4):827-31. DOI: 10.1016/s0735-1097(10)80329-8. View

Gustafsson F, Torp-Pedersen C, Brendorp B, Seibaek M, Burchardt H, Kober L . Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J. 2003; 24(9):863-70. DOI: 10.1016/s0195-668x(02)00845-x. View

Ilksoy N, Hoffman M, Moore R, Easley K, Jacobson T . Comparison of African-American patients with systolic heart failure versus preserved ejection fraction. Am J Cardiol. 2006; 98(6):806-8. DOI: 10.1016/j.amjcard.2006.03.066. View

Aurigemma G, Gaasch W . Clinical practice. Diastolic heart failure. N Engl J Med. 2004; 351(11):1097-105. DOI: 10.1056/NEJMcp022709. View

Varela-Roman A, Grigorian L, Barge E, Bassante P, de la Pena M, Gonzalez-Juanatey J . Heart failure in patients with preserved and deteriorated left ventricular ejection fraction. Heart. 2005; 91(4):489-94. PMC: 1768853. DOI: 10.1136/hrt.2003.031922. View

10.

Philbin E, Rocco Jr T, Lindenmuth N, Ulrich K, Jenkins P . Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med. 2000; 109(8):605-13. DOI: 10.1016/s0002-9343(00)00601-x. View

11.

Eshaghian S, Horwich T, Fonarow G . Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol. 2006; 97(12):1759-64. DOI: 10.1016/j.amjcard.2005.12.072. View

12.

Paulus W, Tschope C, Sanderson J, Rusconi C, Flachskampf F, Rademakers F . How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007; 28(20):2539-50. DOI: 10.1093/eurheartj/ehm037. View

13.

Dries D, Exner D, Domanski M, Greenberg B, Stevenson L . The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000; 35(3):681-9. DOI: 10.1016/s0735-1097(99)00608-7. View

14.

Hettwer S, Panzner-Grote B, Witthaut R, Werdan K . Isolated diastolic dysfunction--diagnostic value of tissue Doppler imaging, colour M-mode and N-terminal pro B-type natriuretic peptide. Clin Res Cardiol. 2007; 96(12):874-82. DOI: 10.1007/s00392-007-0577-x. View

15.

Ahmed A, Rich M, Fleg J, Zile M, Young J, Kitzman D . Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation. 2006; 114(5):397-403. PMC: 2628473. DOI: 10.1161/CIRCULATIONAHA.106.628347. View

16.

Masoudi F, Havranek E, Smith G, Fish R, Steiner J, Ordin D . Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol. 2003; 41(2):217-23. DOI: 10.1016/s0735-1097(02)02696-7. View

17.

Yancy C, Lopatin M, Stevenson L, De Marco T, Fonarow G . Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006; 47(1):76-84. DOI: 10.1016/j.jacc.2005.09.022. View

18.

Zile M, Baicu C, Bonnema D . Diastolic heart failure: definitions and terminology. Prog Cardiovasc Dis. 2005; 47(5):307-13. DOI: 10.1016/j.pcad.2005.02.006. View

19.

Levey A, Coresh J, Greene T, Stevens L, Zhang Y, Hendriksen S . Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145(4):247-54. DOI: 10.7326/0003-4819-145-4-200608150-00004. View

20.

Hogg K, Swedberg K, McMurray J . Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004; 43(3):317-27. DOI: 10.1016/j.jacc.2003.07.046. View